In addition, STN1 downregulation and/or mutations have been reported in a number of cancers, including colorectal cancer, epithelial ovarian cancer, leukemia, thyroid cancer, melanoma, and uterine cancer ([25,26] and references therein). Here, STN1 is linked to melanoma.